Journals / Journal of Basic and Clinical Health Sciences / 2021 / Cilt: 5 - Sayı: 1

Evaluation of the Factors Affecting the Length of Stay in Hospital of Transcatheter Aortic Valve Implantation (TAVI) Cases

Pages
22–29
Publication Date
2021-02-26
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Discussion and Conclusion: Due to the high risks of surgery, it is of vital importance to shorten the length of stay in hospital in high-risk patients over 65 years of age who undergo TAVI.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: In the treatment of inoperable patients with severe aortic stenosis or at high surgical risk, transcatheter aortic valve implantation (TAVI) is applied as an alternative to surgical aortic valve replacement.
📊
Key Findings & Data:Method: After obtaining the approval of the ethics committee, the patients who received TAVI between 09.06.2012-19.01.2018 in the Interventional Cardiology unit of Dokuz Eylül University were retrospectively screened.
💡
Conclusion & Impact:Discussion and Conclusion: Due to the high risks of surgery, it is of vital importance to shorten the length of stay in hospital in high-risk patients over 65 years of age who undergo TAVI.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:TAVI · Sedation · general anesthesia

Abstract

Introduction: In the treatment of inoperable patients with severe aortic stenosis or at high surgical risk, transcatheter aortic valve implantation (TAVI) is applied as an alternative to surgical aortic valve replacement. In our study, it was aimed to evaluate the factors affecting the length of stay in hospital of TAVI cases. Method: After obtaining the approval of the ethics committee, the patients who received TAVI between 09.06.2012-19.01.2018 in the Interventional Cardiology unit of Dokuz Eylül University were retrospectively screened. A total of 243 patients were included in the study. Demographic data, preoperative accompanying diseases and echocardiographic results of the cases, the type of anesthesia applied, the duration of postoperative coronary intensive care, and a hospital stay were recorded. The analysis of the data was carried out in the SPSS 22.0 statistical package program, Results: 53.5% of the patients who underwent transcatheter aortic valve implantation received general anesthesia, 46.5% received local anesthesia and sedation. 93.8% of the patients were discharged upon recovery. There was a significant difference between the postoperative length of stay in the hospital and the type of anesthesia (p=0.008). It was shown that patients who underwent general anesthesia were discharged later than patients who underwent sedation. Discussion and Conclusion: Due to the high risks of surgery, it is of vital importance to shorten the length of stay in hospital in high-risk patients over 65 years of age who undergo TAVI.

🔖

Cite This Article

BÜYÜKÇOBAN, S., İYİLİKÇİ, L. (2021). Evaluation of the Factors Affecting the Length of Stay in Hospital of Transcatheter Aortic Valve Implantation (TAVI) Cases. Journal of Basic and Clinical Health Sciences, Cilt: 5 - Sayı: 1, 22–29. https://ajindex.com/articles/163484

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. KAYNAKLAR 1.Bahar A., Parlar S, Yaşlılık ve Evde Bakım. Fırat sağlık Hizmetleri Dergisi, 2007
  2. 2(4):32-39. 2.E.R. Bates. Treatment options in severe aortic stenosis.Circulation, 124
  3. V.T. Nkomo, J.M.Gardin, T.N. Skelton, J.S. Gottdiener, C.G. Scott, Enriquez-Sarrono. Burden of valvular heart diseases:a population -based study. Lancet,368
  4. 11 4.Vymazal T. Minimally invasive approach to calcified aortic valve replacement: Anaesthetic considerations. Indi Indian J Anaesth 2015
  5. 338–41. 5.Covello RD, Ruggeri L, Landoni G, Guarracino F, Bignami E, Gonfalini M, et al. Transcatheter implantation of an aortic valve: anesthesiological management. Minerva Anestesiol 2010
  6. 100–8. 6.Vahanian A, Alfieri O, Al-Attar N et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS), the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008
  7. 1463–1470(crossref) 7.Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A (2003) A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24:1231–1243 (crossref) 8.Iung B, Cachier A, Baron G et al Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005
  8. 2714–2720(crossref) 9.Conradi L, Seiffert M, Franzen O, Baldus S, Schirmer J, Meinertz T, Reichenspurner H, Treede H (2011) First experience with transcatheter aortic valve implantation, concomitant percutaneous coronary intervention. Clin Res Cardiol 100:311–316(crossref) 10.Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case descrip- tion. Circulation 2002
  9. ) 11.Rex S. Anesthesia for transcatheter aortic valve implantation: an update. Curr Opin Anaesthesiol 2013
  10. 456–66. [CrossRef ] 12.Petronio AS, Giannini C, De Carlo M, Bedogni F, Colombo A, Tamburino C, et al. Anaesthetic management of transcatheter aortic valve implantation: results from the Italian CoreValve registry. EuroIntervention 2016
  11. 381–8. [CrossRef ] 13.Chou WH, Wang YC, Huang HH, Cheng HL, Lin YS, Wang MJ, et al. Transcatheter aortic valve implantatio